Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study. - Thomas JS; Siu LL; Ingham M; Azad NS; Meyer CF; Olszanski AJ; Whalen GF; Camacho LH; Hu JS; Hanna DL; Cheng PM; Abdul Razak AR; et al. (EBioMedicine, 2025)